home / stock / irtc / irtc news


IRTC News and Press, iRhythm Technologies Inc. From 07/06/21

Stock Information

Company Name: iRhythm Technologies Inc.
Stock Symbol: IRTC
Market: NASDAQ
Website: irhythmtech.com

Menu

IRTC IRTC Quote IRTC Short IRTC News IRTC Articles IRTC Message Board
Get IRTC Alerts

News, Short Squeeze, Breakout and More Instantly...

IRTC - Why Did iRhythm Technologies Fall 16% in June?

Shares of healthcare company iRhythm Technologies (NASDAQ: IRTC) dropped by 16% in June after it announced that CEO Michael Coyle would be stepping down. Coyle will stay on with the company to assist in the leadership transition, but this was just the latest in a series of negat...

IRTC - The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025

Palm Beach, FL – June 30, 2021 – Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and much research is devoted to this market. AF is responsible for most arrhythmia-related hospitalizations and leads to the greatest length of hospital stay associated w...

IRTC - AMC, SKLZ, WPG and GSAT among midday movers

Gainers: BriaCell Therapeutics (BCTX) +91%.AMC Entertainment (AMC) +76%.Constellation Pharmaceuticals (CNST) +67%.Bed Bath & Beyond (BBBY) +45%.PetMed Express (PETS) +34%.Urban One (UONE) +31%.Vision Marine Technologies (VMAR) +28%.U.S. Well Services (USWS) +24%.Skillz (SKLZ)&#x...

IRTC - BriaCell Therapeutics, Constellation Pharmaceuticals leads healthcare gainers; iRhythm Technologies, Progenity among major losers

Gainers: BriaCell Therapeutics BCTX +151%, Constellation Pharmaceuticals CNST +67%, Soleno Therapeutics SLNO +46%, Stealth BioTherapeutics (MITO) +24%, Aerpio Pharmaceuticals (ARPO) +9%.Losers: iRhythm Technologies IRTC -18%, Progenity (P...

IRTC - iRhythm downgraded on CEO exit, UBS bullish on aducanumab approval; in today's analyst action

iRhythm cut to neutral at Citi on leadership transitionReaffirmed guidance for the current quarter did not help iRhythm Technologies (IRTC) to avert a sharp selloff in the post-market yesterday after announcing the departure of its CEO Michael Coyle effective June 01.The stock has e...

IRTC - MorphoSys, iRhythm Technologies among major healthcare premarket losers' pack

iRhythm Technologies (IRTC) -15% as CEO departs; Company reaffirms guidanceOrbital Energy Group (OEG) -13%.Protalix BioTherapeutics (PLX) -10% Protalix Biotherapeutics and Chiesi Global Rare Diseases provide update regarding clinical development of PRX-102 for treatment of fabr...

IRTC - iRhythm falls as CEO departs; Company reaffirms guidance

iRhythm Technologies (IRTC) has lost ~8.5% in the post-market after announcing the departure of company President/CEO Michael Coyle effective June 01 due to personal matters.Douglas Devine, the iRhythm’s chief financial officer has assumed the duties as interim CEO ...

IRTC - iRhythm® Technologies Announces Leadership Transition

President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions ...

IRTC - iRhythm Technologies to Present at the 41st Annual William Blair Growth Stock Conference

SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 41 st Annual William Blair Growth Stoc...

IRTC - iRhythm Technologies wins two FDA clearances

iRhythm Technologies (IRTC) has received FDA’s 510K clearances for a new design of its flagship Zio monitor and its updated artificial intelligence ((AI)) capabilities.“iRhythm’s new Zio monitor and enhanced AI further illustrate our commitment to raising the st...

Previous 10 Next 10